Drug and Device Development Outsourcing 2.0 - Soaring Beyond the CRO

January 9, 2023

ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting Organization (RCO) model, a new type of research consulting and clinical service for biotech, pharma and device innovators to deliver bespoke solutions that bring life-saving drugs to market sooner and more cost effectively.


 

Download the Whitepaper

TAGS: Company News

Related Articles

Research Consulting Organization umbrella illustration
Press Releases

January 9, 2023

ProPharma Group launches revolutionary new operating model

$50m investment and rebrand unveiled at J.P. Morgan Healthcare Conference as part of new global growth strategy. RALEIGH, NC, January 9, 2023: ProPharma Group – the end-to-end, global provider of...

Continue reading the blog post
Multiple mobile devices with analytical data
Press Releases

May 9, 2023

ProPharma Announces Strategic Partnership with H1 to Optimize R&D with AI, Data Insights and Analytics

RALEIGH, NC, May 9, 2023, ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and a portfolio company of Odyssey Investment Partners, and H1, a leading healthcare...

Continue reading the blog post
Clinres Farmacija and ProPharma acquisition banner
Press Releases

December 6, 2023

ProPharma Expands into Central and Eastern Europe Through Acquisition of Clinres Farmacija

RALEIGH, NC, December 6, 2023 – ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and compliance services...

Continue reading the blog post